2025 Strategic Guide to the Biosimilar Growth Hormones Market – Forecasts and Business Use Cases

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What is the projected market size of the biosimilar growth hormones industry, and what is its expected CAGR?
 The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising demand for growth hormones, patent expirations, clinical evidence, and increasing clinical trials.
 
 The biosimilar growth hormones market size is expected to see strong growth in the next few years. It will grow to $1.19 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to pediatric growth disorders, expanding indications, increase in the diagnosis, and increased awareness of biosimilar options. Major trends in the forecast period include pediatric-focused biosimilars, biosimilar combinations, dosing convenience, biosimilar combinations, and dosing convenience.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
 
 What external factors are influencing the biosimilar growth hormones market’s growth momentum?
 The growing number of children suffering from growth hormone deficiency is driving the growth of the global biosimilar growth hormone market. Growth hormone deficiency is caused by damage to the pituitary gland or hypothalamus, which may be the result of an abnormal formation that occurred before the child was born (congenital) or something that occurred during or after birth (acquired). For instance, in September 2023, according to Hormones Australia by the Endocrine Society of Australia (ESA), an Australia-based national authority for the treatment of endocrine related conditions and disease, growth hormone deficiency is estimated to affect 2 to 3 out of every 10,000 people. Therefore, an increase in the number of children suffering from growth deficiencies drives the growth of the biosimilar growth hormones industry.
 
 What are the major market segments driving the growth of the biosimilar growth hormones industry?
 The biosimilar growth hormones market covered in this report is segmented –
 
 1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
 2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
 3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics
 
 Subsegments:
 1) By Intravenous: Hospital-based Administration, Outpatient Clinics
 2) By Subcutaneous: Self-administration, Professional Administration
 3) By Intramuscular: Pediatric Care, Adult Care
 4) By Oral: Tablets, Capsules
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
 
 Which trends are expected to dominate the biosimilar growth hormones market landscape in the coming years?
 Major companies operating in the biosimilar growth hormones market are innovating solutions such as human growth hormone to enhance treatment efficacy and affordability for growth hormone deficiencies. Growth hormone solutions refer to medical treatments or supplements designed to stimulate or replace human growth hormone (HGH) in the body for growth deficiencies or anti-aging purposes. For instance, in June 2023, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based healthcare company, received US Food and Drug Administration (FDA) approval for NGENLA (somatrogon-ghla). It is a once-weekly injectable human growth hormone treatment designed for pediatric patients with growth hormone deficiency (GHD). This long-acting growth hormone therapy offers an alternative to daily injections, which can improve adherence and convenience for patients and caregivers. Approval was based on clinical studies demonstrating its efficacy and safety, marking an important advancement in growth hormone therapies.
 
 Who are the key market players contributing to the growth of the biosimilar growth hormones industry?
 Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation
 
 Which regions are leading the growth of the biosimilar growth hormones market globally?
 The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
 
 How Can Companies Use The Biosimilar Growth Hormones Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3391
 
 Need Customized Data On Biosimilar Growth Hormones Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=3391&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Europe +44 7882 955267
 Asia & Others +44 7882 955267 & +91 8897263534
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company